tiprankstipranks
Holding DE:0V1H?
Track your performance easily

DE:0V1H ETF Forecast & Price Targets

See the Price Targets and Ratings of:

0V1H Analyst Ratings

Moderate Buy
3KConsensusRatings
2027 Buy
1360 Hold
68 Sell
Based on the consensus analyst ratings on 3,455 stocks held in DE:0V1H.
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

0V1H 12 Month Forecast

Average Price Target

€207.93
Based on 3,455 Wall Street analysts offering 12 month price targets to DE:0V1H holdings in the last 3 months. The average price target is €207.93 with a high forecast of €244.02 and a low forecast of €173.94. The average price target represents a 12.56% change from the last price of €184.72.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"125":"€125","155":"€155","185":"€185","215":"€215","245":"€245"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":244.016,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€244.02</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":207.927,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€207.93</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":173.936,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€173.94</span>\n  </div></div>","useHTML":true}}],"tickPositions":[125,155,185,215,245],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Feb<br/>2024","6":"May<br/>2024","9":"Aug<br/>2024","12":"Nov<br/>2024","25":"Nov<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n              \n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,169.62,175.34276923076922,181.06553846153847,186.78830769230768,192.51107692307693,198.23384615384614,203.9566153846154,209.6793846153846,215.40215384615385,221.12492307692307,226.8476923076923,232.57046153846153,238.29323076923077,{"y":244.016,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,169.62,172.5666923076923,175.5133846153846,178.46007692307694,181.40676923076924,184.35346153846154,187.30015384615385,190.24684615384615,193.19353846153845,196.14023076923075,199.08692307692309,202.0336153846154,204.9803076923077,{"y":207.927,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,169.62,169.952,170.284,170.616,170.948,171.28,171.612,171.94400000000002,172.276,172.608,172.94,173.27200000000002,173.604,{"y":173.936,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":126.181,"date":1698796800000,"info":"<div>Price: <b>€126<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":138.838,"date":1701388800000,"info":"<div>Price: <b>€139<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":146.609,"date":1704153600000,"info":"<div>Price: <b>€147<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":148.176,"date":1706745600000,"info":"<div>Price: <b>€148<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":156.781,"date":1709251200000,"info":"<div>Price: <b>€157<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":157.874,"date":1712016000000,"info":"<div>Price: <b>€158<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":154.912,"date":1714608000000,"info":"<div>Price: <b>€155<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":153.739,"date":1717372800000,"info":"<div>Price: <b>€154<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":155.981,"date":1719792000000,"info":"<div>Price: <b>€156<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":160.269,"date":1722470400000,"info":"<div>Price: <b>€160<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":161.745,"date":1725235200000,"info":"<div>Price: <b>€162<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":162.96,"date":1727740800000,"info":"<div>Price: <b>€163<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":169.62,"date":1730419200000,"info":"<div>Price: <b>€170<b/></div>","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€244.02Average Price Target€207.93Lowest Price Target€173.94
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

0V1H Stocks With Highest Upside Potential

Name
Price & Change
Analyst Consensus
Analyst Price Target
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Alzamend Neuro, Inc.
1 Buy
0 Hold
0 Sell
Moderate Buy
$50.00
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Nrx Pharmaceuticals, Inc.
2 Buy
0 Hold
0 Sell
Moderate Buy
$37.50
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Aptevo
1 Buy
0 Hold
0 Sell
Moderate Buy
$8.00
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Imunon, Inc.
2 Buy
0 Hold
0 Sell
Moderate Buy
$20.50
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Scilex Holding Company
1 Buy
0 Hold
0 Sell
Moderate Buy
$14.00

0V1H Stocks With Highest Downside Potential

No stocks with downside potential were found for this ETF
Please check back later or explore other ETFs for potential investment opportunities.

0V1H ETF FAQ

What is DE:0V1H’s average 12-month price target, according to analysts?
Based on analyst ratings, DE:0V1H’s 12-month average price target is €207.93.
    What is DE:0V1H’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for DE:0V1H, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is DE:0V1H a Buy, Sell or Hold?
        DE:0V1H has a consensus rating of Moderate Buy which is based on 2027 buy ratings, 1360 hold ratings and 68 sell ratings.
          What is DE:0V1H’s price target?
          The average price target for DE:0V1H is €207.93. This is based on 3455 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst price target is €244.02 ,the lowest forecast is €173.94. The average price target represents N/A Increase from the current price of N/A.
            What do analysts say about DE:0V1H?
            DE:0V1H’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 3455 Wall Streets Analysts.
              How can I buy shares of DE:0V1H?
              Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis